WikiPatents - Community Patent Review
Create Free Account  |  License or Sell Your Patent  |  WikiPatents Marketplace  |  WikiPatents Blog
Username:  Password:  
    
Advanced Search
Integrated nucleic acid diagnostic device    

Get related patents on CD
United States Patent5922591   
Link to this pagehttp://www.wikipatents.com/5922591.html
Inventor(s)Anderson; Rolfe C. (Mountain View, CA); Lipshutz; Robert J. (Palo Alto, CA); Rava; Richard P. (San Jose, CA); Fodor; Stephen P. A. (Palo Alto, CA)
AbstractThe present invention provides a miniaturized integrated nucleic acid diagnostic device and system. The device of the invention is generally capable of performing one or more sample acquisition and preparation operations, in combination with one or more sample analysis operations. For example, the device can integrate several or all of the operations involved in sample acquisition and storage, sample preparation and sample analysis, within a single integrated unit. The device is useful in a variety of applications, and most notably, nucleic acid based diagnostic applications and de novo sequencing applications.
   














 Title Information Submit all comments and votes
 
Patent Text Patent PDF Print Page Summary File History
Plain text PDF images Print Summary File History Custom Search
Drawing from US Patent 5922591
Integrated nucleic acid diagnostic device - US Patent 5922591 Drawing
Integrated nucleic acid diagnostic device
Inventor     Anderson; Rolfe C. (Mountain View, CA); Lipshutz; Robert J. (Palo Alto, CA); Rava; Richard P. (San Jose, CA); Fodor; Stephen P. A. (Palo Alto, CA)
Owner/Assignee     Affymetrix, Inc. (Santa Clara, CA)
Patent assignment
All assignments
Company News
Publication Date     July 13, 1999
Application Number     08/671,928
PAIR File History     Application Data   Transaction History
Image File Wrapper   Patent Term   Fees
Litigation
Filing Date     June 27, 1996
US Classification     435/287.2 422/68.1 422/100 422/102 435/288.5 435/288.6 435/288.7
Int'l Classification     C12M 001/34
Examiner     Beisner; William H.
Assistant Examiner    
Attorney/Law Firm     Townsend & Townsend & Crew
Address
Parent Case     CROSS REFERENCE TO RELATED APPLICATIONS The present application is a regular application claiming priority from Provisional U.S. patent application Ser. No. 60/000,703, filed Jun. 29, 1995, and Provisional U.S. patent application Ser. No. 60/000859, filed Jul. 3, 1995. This application is also a continuation-in-part of U.S. patent application Ser. No. 08/589,027, filed Jan. 19, 1996, now U.S. Pat. No. 5,856,174. Each of these applications is incorporated herein by reference in its entirety for all purposes.
Priority Data    
USPTO Field of Search     435/6 435/91.1 435/91.2 435/286.5 435/286.6 435/287.2 435/287.3 435/288.4 435/288.5 435/288.7 435/288.6 435/305.2 422/68.1 422/82.05 422/100 422/102
Patent Tags     integrated nucleic acid diagnostic
   
Enter a comma (,) or semicolon (;) between multiple tag words/phrases.
Describe this patent:
 Amusing   
 Clever   
 Complex   
 Efficient   
 Historic   
 Important   
 Innovative   
 Interesting   
 Practical   
 Simple   
[no votes]
Patent WIKI

Share information and news about this patent, including information and news about the technology, inventors, company, ligation and licensing.

 References Submit all comments and votes
 
*references marked with an asterisk below are user-added references
 U.S. References
 
Add a new US reference:  
ReferenceRelevancyCommentsReferenceRelevancyComments
5700637
Southern
435/6
Dec,1997

[0 after 0 votes]
5660993
Cathey
435/7.9
Aug,1997

[0 after 0 votes]
5653939
Hollis
422/50
Aug,1997

[0 after 0 votes]
5593130
Hansson
251/61.1
Jan,1997

[0 after 0 votes]
5589350
Bochner
435/29
Dec,1996

[0 after 0 votes]
5587128
Wilding
422/50
Dec,1996

[0 after 0 votes]
5498392
Wilding
422/68.1
Mar,1996

[0 after 0 votes]
5486335
Wilding
422/55
Jan,1996

[0 after 0 votes]
5436129
Stapleton
435/6
Jul,1995

[0 after 0 votes]
5424186
Fodor
435/6
Jun,1995

[0 after 0 votes]
5384261
Winkler
436/518
Jan,1995

[0 after 0 votes]
5382511
Stapleton
435/6
Jan,1995

[0 after 0 votes]
5375979
Trah
417/52
Dec,1994

[0 after 0 votes]
5346672
Stapleton
422/102
Sep,1994

[0 after 0 votes]
5313264
Ivarsson
356/73
May,1994

[0 after 0 votes]
5304487
Wilding
435/29
Apr,1994

[0 after 0 votes]
5296375
Kricka

Mar,1994

[0 after 0 votes]
5281516
Stapleton
435/3
Jan,1994

[0 after 0 votes]
5277556
van Lintel
417/413.2
Jan,1994

[0 after 0 votes]
5271724
van Lintel
417/413.2
Dec,1993

[0 after 0 votes]
5252294
Kroy
422/102
Oct,1993

[0 after 0 votes]
5230866
Shartle
422/103
Jul,1993

[0 after 0 votes]
5188963
Stapleton
435/288.3
Feb,1993

[0 after 0 votes]
5171132
Miyazaki
417/413.1
Dec,1992

[0 after 0 votes]
5143854
Pirrung
436/518
Sep,1992

[0 after 0 votes]
5126022
Soane
204/458
Jun,1992

[0 after 0 votes]
4426451
Columbus
436/518
Dec,1969

[0 after 0 votes]
5451500
Stapleton
435/6
Dec,1969

[0 after 0 votes]
 Foreign References
 Other References
 Market Review Submit all comments and votes
   
Market Size
Estimate the gross annual revenues of the relevant market sector:
> $10B
$5B - $10B
$2B - $5B
$500M - $2B
$100M - $500M
$10M - $100M
$1M - $10M
$500K - $1M
$100K - $500K
< $100K
[No votes]
$0
 
$0   $2.5B   $5B   $7.5B   $10B

[0 market size comments]
Market Share
Estimate the percentage of the relevant market sector this invention will capture:
75% - 100%
50% - 74.99%
25% - 49.99%
10 - 24.99%
5 - 9.99%
2 - 4.99%
1 - 1.99%
< 1%
[No votes]
0.0%
 
0%   25%   50%   75%   100%

[0 market share comments]
Reasonable Royalty
What percentage of gross sales should the inventor or assignee be paid?
75% - 100%
50% - 74.99%
25% - 49.99%
10 - 24.99%
5 - 9.99%
2 - 4.99%
1 - 1.99%
< 1%
[No votes]
0.0%
 
0%   25%   50%   75%   100%

[0 reasonable royalty comments]
Public's "Guesstimation" of Royalty Value
Market SizeN/A[No votes]
xMarket ShareN/A[No votes]
xReasonable RoyaltyN/A[No votes]

N/A

[0 Guesstimation of Royalty Value Comments]
License Availablity
If you are NOT the owner or assignee, answer here:
Yes, license is available for purchase

No, license is not currently available



[No votes]
[0 license availability comments]
License Availablity
If you ARE the owner or assignee, answer here:
Yes, license is available for purchase

No, license is not currently available



[No votes]
[0 owner/assignee comments]
Competitive Advantage
Does this invention have a significant competitive advantage over similar technologies?
Yes

No



[No votes]
Most helpful competitive advantage comment
[No comments]

[0 competitive advantage comments]
Commercial Alternatives
Are there viable commercial alternatives for this invention?
Yes

No



[No votes]
Most helpful commercial alternative comment
[No comments]

[0 commercial alternatives comments]
 Technical Review Submit all comments and votes
 Claims Submit all comments and votes
 


What is claimed is:

1. A miniature fluidic system, comprising:

a body having at least two discrete reaction chambers, each of said reaction chambers comprising at least one vent port, and wherein each of said reaction chambers is fluidly connected to a common chamber or channel by a fluidic inlet having a controllable diaphragm valve disposed thereacross; and

a pneumatic system for selectively applying a pressure differential between said common channel or chamber and at least a selected one of said at least two discrete chambers, whereby said pressure differential directs a fluid sample in said body between said common channel or chamber and said at least one selected chamber.

2. The system of claim 1, wherein said vent port comprises a gas permeable fluid barrier disposed across said vent port.

3. The system of claim 2, wherein said gas permeable fluid barrier is a hydrophobic membrane.

4. The system of claim 1, wherein at least one of said at least two chambers is a debubbling chamber, said debubbling chamber comprising at least two vent ports, one of said at least two vent ports being disposed at an intermediate position in said chamber, whereby a bubble separating at least two discrete fluid plugs in said chamber may exit said chamber allowing said at least two discrete fluid plugs to connect.

5. The system of claim 1, wherein said pneumatic system is further capable of applying a pressure differential to said diaphragm valve to deflect said diaphragm valve.

6. The system of claim 5, wherein deflection of said diaphragm valve opens said fluid connection.

7. The system of claim 1, wherein each of said chambers has a cross sectional dimension of from about 0.05 to about 20 mm, and a depth dimension of from about 0.05 to about 5 mm.

8. The system of claim 1, wherein said at least two chambers are fluidly connected via a fluid passage, said fluid passage having a cross-sectional dimension of from about 10 .mu.m to about 1000 .mu.m, and a depth dimension of from about 1 to 500 .mu.m.

9. The system of claim 1, wherein said pneumatic system comprises a pneumatic manifold for applying a differential pressure between said at least first chamber and said at least second chamber, to move said fluid sample from said at least first chamber to said at least second chamber.

10. The system of claim 1, wherein said pneumatic system comprises a differential pressure delivery system for maintaining said at least first chamber at a first pressure and said second chamber at a second pressure, said first pressure being greater than ambient pressure and said second pressure being greater than said first pressure, whereby when said second chamber is brought to ambient pressure, said first pressure forces a liquid sample in said first chamber into said second chamber.

11. The system of claim 10 wherein said differential pressure delivery system comprises:

a pressure source;

at least first and second passages fluidly connecting said pressure source to said at least first and second chambers, respectively;

a first fluidic resistance disposed in said first passage between said pressure source and said first chamber, said first fluidic resistance transforming a pressure from said pressure source to said first pressure;

a second fluidic resistance disposed in said second passage between said pressure source and said second chamber, said second fluidic resistance transforming said pressure from said pressure source to said second pressure; and

first and second openable closures in said first and second chambers, respectively, whereby opening of said first or second closures allows said first or second chambers to achieve ambient pressure.

12. The miniature system of claim 11, wherein said first and second fluidic resistances independently comprise one or more fluid passages connecting said first and second passages to said first and second chambers, said first fludic reistance having a smaller cross-sectional area than said second fluidic resistance.

13. The system of claim 1, wherein said pneumatic system comprises a differential pressure delivery system for maintaining said first chamber at a first pressure and said second chamber at a second pressure, said second pressure being less than ambient pressure and said first pressure being less than said second pressure, whereby when said first chamber is brought to ambient pressure, said second pressure draws a liquid sample in said first chamber into said second chamber.

14. The system of claim 13, wherein said differential pressure delivery system comprises:

a pressure source;

at least first and second passages fluidly connecting said pressure source to said at least first and second chambers, respectively;

a first fluidic resistance disposed in said first passage between said pressure source and said first chamber, said first fluidic resistance transforming a pressure from said pressure source to said first pressure;

a second fluidic resistance disposed in said second passage between said pressure source and said second chamber, said second fluidic resistance transforming said pressure from said pressure source to said second pressure; and

first and second openable closures in said first and second chambers, respectively, whereby opening of said first or second closures allows said first or second chambers to achieve ambient pressure.

15. The system of claim 14, wherein said first and second fluidic resistances independently comprise one or more fluid passages connecting said first and second passages to said first and second chambers, said first fludic reistance having a larger cross-sectional area than said second fluidic resistance.

16. The system of claim 1, wherein said system further includes a temperature controller disposed adjacent at least one of said at least two chambers, for controlling a temperature within said at least one chamber.

17. The system of claim 16, wherein said temperature controller comprises a thermoelectric temperature controller.

18. The system of claim 16, wherein said temperature controller comprises a resistive heater.

19. The system of claim 18, wherein said resistive heating element is a NiCr/polyimide/copper laminate heating element.

20. The system of claim 16, further comprising a temperature sensor disposed within said temperature controlled chamber.

21. The system of claim 20, wherein said temperature sensor is a thermocouple.

22. The system of claim 20, wherein said temperature sensor is a resistance thermometer.

23. The system of claim 1, wherein at least one of said at least two chambers is a cell lysis chamber and comprises a cell lysis system disposed therein, for lysing cells in a fluid sample.

24. The system of claim 23, wherein said cell lysis system comprises an acoustic energy source disposed adjacent said cell lysis chamber.

25. The system of claim 23, wherein said cell lysis chamber includes microstructures fabricated on an internal surface of said cell lysis chamber for enhancing cell lysis.

26. The system of claim 23, wherein said cell lysis chamber includes an electrolytic pH control system for altering a pH of said cell lysis chamber.

27. The system of claim 1, wherein at least one of said at least two chambers is a hybridization chamber for analyzing a component of a fluid sample, said hybridization chamber including a polymer array, said polymer array including a plurality of different polymer sequences coupled to a surface of a single substrate, each of said plurality of different polymer sequences being coupled to said surface in a different, known location.

28. The system of claim 27, wherein said polymer array comprises at least 100 different polymer sequences coupled to said surface of said single substrate, each of said plurality of different polymer sequences being coupled to said surface in a different, known location.

29. The system of claim 27, wherein said polymer array comprises at least 1000 different polymer sequences coupled to said surface of said single substrate, each of said plurality of different polymer sequences being coupled to said surface in a different, known location.

30. The system of claim 27, wherein said polymer array comprises at least 10,000 different polymer sequences coupled to said surface of said single substrate, each of said plurality of different polymer sequences being coupled to said surface in a different, known location.

31. The system of claim 1, wherein at least one of said at least two chambers comprises a nucleic acid amplification system.

32. The system of claim 31, wherein said nucleic acid amplification includes a system for cycling a fluid sample in said at least one chamber between at least two different temperatures.

33. The system of claim 32, wherein said system for cycling comprises at least two separate temperature controlled chambers, said at least two chambers being maintained at at least two different temperatures, whereby said sample is cycled between said at least two temperatures by moving said fluid sample back and forth between said at least two temperature controlled chambers.

34. The system of claim 1, wherein at least one of said at least two chambers comprises a nucleic acid purification system for separating nucleic acids in said sample from other contaminants in said sample.

35. The system of claim 34, wherein said nucleic acid purification system comprises a separation matrix for separating said nucleic acids from said contaminants.

36. The system of claim 35, wherein said separation matrix comprises functional groups for preferentially binding said nucleic acids in said sample.

37. The system of claim 36, wherein said functional groups comprise poly-T oligonucleotides.

38. The system of claim 35, wherein said nucleic acid purification system further comprises an electrophoretic system for applying an electric field to said fluid sample to separate said nucleic acids from said contaminants.

39. The system of claim 35, wherein said separation matrix comprises a gel matrix.

40. The system of claim 35, wherein said separation matrix comprises a membrane disposed between said sample and an anode of said electrophoretic system.

41. The system of claim 1, wherein at least one of said at least two chambers is a reverse transcription chamber, said reverse transcription chamber having disposed therein an effective amount of a reverse transcriptase enzyme and the at least four deoxynucleoside triphosphates.

42. The system of claim 1, wherein at least one of said at least two chambers is an in vitro transcription chamber, said in vitro transcription chamber having an effective amount of an RNA polymerase and at least four different nucleoside triphosphates, disposed therein.

43. The system of claim 1, wherein at least one of said at least two chambers comprises a nucleic acid fragmentation system, for fragmenting a nucleic acid in a fluid sample.

44. The system of claim 43, wherein said fragmentation system comprises a focused piezoelectric element disposed adjacent said fragmentation chamber.

45. The system of claim 44, wherein said fragmentation system further comprises a series of microstructures fabricated on a first surface of said chamber.

46. The system of claim 43, wherein said fragmentation system comprises at least one channel through which said fluid sample is pumped, said channel having a submicron cross-sectional dimension for generating a high-shear rate.

47. The system of claim 1, further comprising a fluid mixing system for mixing said fluid sample within at least one of said at least two chambers.

48. The system of claim 47, wherein said fluid mixing system comprises a piezoelectric element disposed adjacent at least one of said at least two chambers.

49. The system of claim 47, wherein said fluid mixing system comprises a separate chamber adjacent to and fluidly connected to said at least one of said at least two chambers, whereby said fluid sample is flowed between said at least one chamber and said separate chamber to mix said fluid sample.

50. The system of claim 47, wherein said mixing system comprises:

a plurality of metallic particles disposed within said at least one chamber;

an electromagnetic field generator adjacent said at least one chamber, whereby when said electromagnetic field generator is activated, said metallic particles are vibrated within said at least one chamber mixing contents of said chamber.

51. The system of claim 47, wherein said mixing system mixes a fluid sample contained in a hybridization chamber.

52. A miniature fluidic system, comprising:

a body having at least first and second chambers disposed therein, at least one of said first and second chambers having a vent port with a gas/liquid separator disposed thereacross, each of said at least first and second chambers having a fluid inlet with a controllable diaphragm valve disposed thereacross, said at least first and second chambers being in fluid connection, and at least one of said at least first and second chamber being a hybridization chamber for analyzing a component of a fluid sample, said hybridization chamber including a polymer array, said polymer array including a plurality of different polymer sequences coupled to a surface of a single substrate, each of said plurality of different polymer sequences being coupled to said surface in a different, known location;

a sample inlet, fluidly connected to at least one of said first and second chambers, for introducing a fluid sample into said system;

a fluid transport system for moving a fluid sample from said at least first chamber to said at least second chamber.

53. The system of claim 52, wherein said polymer array comprises at least 100 different polymer sequences coupled to said surface of said single substrate, each of said plurality of different polymer sequences being coupled to said surface in a different, known location.

54. The system of claim 52, wherein said polymer array comprises at least 1000 different polymer sequences coupled to said surface of said single substrate, each of said plurality of different polymer sequences being coupled to said surface in a different, known location.

55. The system of claim 52, wherein said polymer array comprises at least 10,000 different polymer sequences coupled to said surface of said single substrate, each of said plurality of different polymer sequences being coupled to said surface in a different, known location.

56. The system of claim 52, wherein said body further comprises a transparent region disposed over said hybridization chamber for detecting hybridization of a component of said fluid sample to said polymer array.

57. The system of claim 52, wherein said fluid transport system comprises a micropump disposed in said body and fluidly connected to at least one of said plurality of chambers.

58. The system of claim 57, wherein said micropump comprises an electrophoretic pump.
 Description Submit all comments and votes
 


BACKGROUND OF THE INVENTION

The relationship between structure and function of macromolecules is of fundamental importance in the understanding of biological systems. These relationships are important to understanding, for example, the functions of enzymes, structure of signalling proteins, ways in which cells communicate with each other, as well as mechanisms of cellular control and metabolic feedback.

Genetic information is critical in continuation of life processes. Life is substantially informationally based and its genetic content controls the growth and reproduction of the organism. The amino acid sequences of polypeptides, which are critical features of all living systems, are encoded by the genetic material of the cell. Further, the properties of these polypeptides, e.g., as enzymes, functional proteins, and structural proteins, are determined by the sequence of amino acids which make them up. As structure and function are integrally related, many biological functions may be explained by elucidating the underlying structural features which provide those functions, and these structures are determined by the underlying genetic information in the form of polynucleotide sequences. In addition to encoding polypeptides, polynucleotide sequences can also be specifically involved in, for example, the control and regulation of gene expression.

The study of this genetic information has proved to be of great value in providing a better understanding of life processes, as well as diagnosing and treating a large number of disorders. In particular, disorders which are caused by mutations, deletions or repeats in specific portions of the genome, may be readily diagnosed and/or treated using genetic techniques. Similarly, disorders caused by external agents may be diagnosed by detecting the presence of genetic material which is unique to the external agent, e.g., bacterial or viral DNA.

While current genetic methods are generally capable of identifying these genetic sequences, such methods generally rely on a multiplicity of distinct processes to elucidate the nucleic acid sequences, with each process introducing a potential for error into the overall process. These processes also draw from a large number of distinct disciplines, including chemistry, molecular biology, medicine and others. It would therefore be desirable to integrate the various process used in genetic diagnosis, in a single process, at a minimum cost, and with a maximum ease of operation.

Interest has been growing in the fabrication of microfluidic devices. Typi